Author information:
(1)Molecular Oncology and Viral Pathology Group, IPO-Porto Research Center 
(CI-IPOP), Portuguese Institute of Oncology of Porto, 4200-072 Porto, Portugal. 
augusto.andre.nogueira@ipoporto.min-saude.pt.
(2)Faculty of Medicine of University of Porto (FMUP), 4200-319 Porto, Portugal. 
augusto.andre.nogueira@ipoporto.min-saude.pt.
(3)Molecular Oncology and Viral Pathology Group, IPO-Porto Research Center 
(CI-IPOP), Portuguese Institute of Oncology of Porto, 4200-072 Porto, Portugal. 
mara.aires.fernandes@ipoporto.min-saude.pt.
(4)Faculty of Medicine of University of Porto (FMUP), 4200-319 Porto, Portugal. 
mara.aires.fernandes@ipoporto.min-saude.pt.
(5)Molecular Oncology and Viral Pathology Group, IPO-Porto Research Center 
(CI-IPOP), Portuguese Institute of Oncology of Porto, 4200-072 Porto, Portugal. 
raquelcatarino@gmail.com.
(6)Molecular Oncology and Viral Pathology Group, IPO-Porto Research Center 
(CI-IPOP), Portuguese Institute of Oncology of Porto, 4200-072 Porto, Portugal. 
ruimedei@ipoporto.min-saude.pt.
(7)Faculty of Medicine of University of Porto (FMUP), 4200-319 Porto, Portugal. 
ruimedei@ipoporto.min-saude.pt.
(8)Biomedical Research Center (CEBIMED), Faculty of Health Sciences of Fernando 
Pessoa University, 4249-004 Porto, Portugal. ruimedei@ipoporto.min-saude.pt.
(9)Research Department, Portuguese League against Cancer (NRNorte), 4200-172 
Porto, Portugal. ruimedei@ipoporto.min-saude.pt.